CTTI forms patient leadership council to drive improvements in clinical trials

Friday, February 15, 2013 10:50 AM

 As part of an effort to improve the way clinical trials are conducted, the Clinical Trials Transformation Initiative (CTTI), a public-private partnership to identify practices to increase the quality and efficiency of clinical trials, has formed a 16-member council to engage patient advocates in its mission.

The newly formed Patient Leadership Council (PLC) brings together leaders from advocacy groups and voluntary health agencies to participate in finding innovative solutions to challenges such as patient recruitment and retention.

“Members of the Patient Leadership Council are experienced leaders of patient advocacy organizations who individually advocate for specific diseases or patient groups. Through the Patient Leadership Council, CTTI provides an unprecedented opportunity for knowledgeable and passionate patient advocates to bring a collective voice around the real world ‘urgency’ to improve the clinical trial process,” said Cindy Geoghegan, PLC co-chair, patient advocate and principal of Patient & Partners. “We all want to ensure that safe and impactful research is completed as quickly as possible in order to improve patient outcomes.”

Established by the FDA and Duke University as a public-private partnership in 2007, CTTI comprises more than 60 member organizations working to identify and promote practices that will increase the quality and efficiency of clinical trials. The FDA and European regulators have cited this work in their efforts to modernize clinical trials.

“The FDA has always been a strong supporter of increased patient engagement in clinical research," said Rachel Sherman, M.D., associate director for medical policy in FDA’s Center for Drug Evaluation and Research (CDER). "The Patient Leadership Council will amplify and extend the critical contributions that the patient advocate members have already made to this important initiative.”

Veronica Todaro, MPH, director of national programs for the Parkinson's Disease Foundation, and co-chair of the PLC, added, “The creation of the Patient Leadership Council is a critical first step in recognizing that the CTTI vision of a patient-centered clinical trials enterprise begins by creating and embracing new models of collaboration—one where patients and patient advocates are partners and drivers in all aspects of the clinical trial process.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs